| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |